Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has provided an update.
Shandong Weigao Group Medical Polymer Company Limited reported a slight decrease in revenue for the year ended December 31, 2024, with a total of approximately RMB13.09 billion, down 1.1% from the previous year. However, the company achieved a 3.2% increase in net profit attributable to its owners, reaching approximately RMB2.07 billion. The directors have recommended a final dividend of RMB0.1235 per share, pending shareholder approval. This financial performance highlights the company’s resilience and potential for growth despite a challenging market environment.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates in the medical polymer industry, focusing on the production and distribution of medical devices and related products.
YTD Price Performance: 17.14%
Average Trading Volume: 700
Technical Sentiment Signal: Buy
Current Market Cap: $2.95B
Find detailed analytics on 1066 stock on TipRanks’ Stock Analysis page.